Erythropoietin and spontaneous platelet aggregation in haemodialysis patients

J.E. Taylor, I.S. Henderson, W.K. Stewart, J.J.F. Belch

    Research output: Contribution to journalArticlepeer-review

    61 Citations (Scopus)


    Erythropoietin significantly, reversibly, and reproducibly increased in-vitro whole-blood spontaneous platelet aggregation in 15 patients on haemodialysis. During erythropoietin treatment, spontaneous platelet aggregation was significantly higher in these subjects than in non-uraemic controls; concomitant treatment with 300 mg aspirin daily reversed platelet hyperaggregability. Erythropoietin may promote thrombosis by an effect on platelet function.
    Original languageEnglish
    Pages (from-to)1361-13622
    Number of pages2
    Issue number8779
    Publication statusPublished - 30 Nov 1991


    Dive into the research topics of 'Erythropoietin and spontaneous platelet aggregation in haemodialysis patients'. Together they form a unique fingerprint.

    Cite this